Gpx4 inhibitors, pharmaceutical compositions thereof, and their use for treating gpx4-mediated diseases
US-2024246901-A1 · Jul 25, 2024 · US
US9908856B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9908856-B2 |
| Application number | US-201515121324-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 26, 2015 |
| Priority date | Feb 26, 2014 |
| Publication date | Mar 6, 2018 |
| Grant date | Mar 6, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides compounds and compositions that are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, and psychotic disorders such as schizophrenia.
Opening claim text (preview).
What is claimed is: 1. A compound of formulae II: wherein: X is N, Y is CH and Z is N; X is N, Y is CH and Z is CH; X is N, Y is N and Z is CH; X is CH, Y is CH and Z is CH; R 2 is H or methyl; and R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br; wherein the ring containing X, Y, and Z is optionally substituted on carbon with one or more groups independently selected from halo; or a salt thereof provided the compound is not: 2. The compound of claim 1 which is a compound of formulae IIa, IIb, or IIc: wherein: R 2 is H or methyl; and R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br; or a salt thereof. 3. The compound of claim 1 which is a compound of formulae IIa or IIc: wherein: R 2 is H or methyl; and R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br; or a salt thereof. 4. The compound of claim 1 which is a compound of formulae IIc: wherein: R 2 is H or methyl; and R 3 is ethyl that is optionally substituted with one or more groups independently selected from F, Cl, and Br; or a salt thereof. 5. A compound selected from: or a salt thereof. 6. A compound selected from: or a salt thereof. 7. The compound, or a salt thereof. 8. A compound selected from the group consisting of: or a salt thereof. 9. A compound selected from the group consisting of: or a salt thereof.
Radicals substituted by halogen atoms or nitro radicals · CPC title
Aldehydo radicals · CPC title
One nitrogen atom (nitro radicals C07D239/30) · CPC title
in which said hetero-bound carbon atoms have double bonds to oxygen, sulfur or nitrogen atoms · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.